Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL

Abroad (travel likely)RecruitingPHASE1

Conditions

Lymphoma · Primary Central Nervous System Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Brigham and Women's Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Lakshmi Nayak, MD) · Lakshmi_Nayak@DFCI.HARVARD.EDU · 617-632-2166
Contact: Principal Investigator (Lakshmi Nayak, MD)
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Study coordinator (Lakshmi Nayak, MD) · Lakshmi_Nayak@DFCI.HARVARD.EDU · (617) 632-2166
Contact: Principal Investigator (Lakshmi Nayak, MD)

Study leads

Lakshmi Nayak, MD
Principal Investigator
Dana-Farber Cancer Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis

Acute Myelogenous Leukemia · Acute Lymphatic Leukemia · Chronic Myelogenous Leukemia

Abroad (travel likely)RecruitingPHASE2

Cleveland, United States

Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma

Lymphoma · Gene Abnormality

Abroad (travel likely)Recruiting

Zhengzhou, China

Role of Spectral CT in the Evaluation of Cardiotoxicity in Patients With Hodgkin's Lymphoma and Diffuse Large B-cell Lymphoma Treated With Anthracyclines

Cardiac Imaging · Cardiac Imaging Techniques · Lymphoma

Abroad (travel likely)Recruiting

Bologna, Italy

Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochemotherapy in Elderly PCNSL Patients

Primary Central Nervous System Lymphoma

Abroad (travel likely)RecruitingPHASE3

Freiburg im Breisgau, Germany · Stuttgart, Germany